Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05247255 · ClinicalTrials.gov registry record · Early Phase 1
Quadratus Lumborum Block for Total Hip Arthroplasty
A Early Phase 1 study of Pain, Postoperative, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05247255: Recruiting Early Phase 1 study of Pain, Postoperative, sponsored by University of California, Los Angeles.
NCT05247255 is a Early Phase 1 study of Pain, Postoperative that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 80 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05247255, a Early Phase 1 study of Pain, Postoperative, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).
Conditions Studied
Interventions
- DRUG Placebo Comparator
- DRUG Active Comparator
Study Locations (1)
California
- UCLA Medical Center, Santa Monica - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-03-29 |
| Est. Completion | 2027-01 |
| Phase | Early Phase 1 |
What NCT05247255 shows while recruiting
NCT05247255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT05247255 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05247255 about?
NCT05247255 is a clinical study titled "Quadratus Lumborum Block for Total Hip Arthroplasty". The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).
What is the current status of trial NCT05247255?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2022-03-29. Estimated completion is 2027-01.
What conditions does trial NCT05247255 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT05247255?
The interventions under investigation include: Placebo Comparator (DRUG), Active Comparator (DRUG).
Who is sponsoring clinical trial NCT05247255?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05247255 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05247255's enrollment target sits among peer trials
80 56th of 113 higher than 53 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery
RECRUITING · Early Phase 1
-
Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty
COMPLETED · Early Phase 1
-
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia
COMPLETED · Early Phase 1
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI